Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001 Dec;62(12):1371-81.
doi: 10.1016/s0198-8859(01)00346-9.

The major histocompatibility complex influences the ethiopathogenesis of MS-like disease in primates at multiple levels

Affiliations
Review

The major histocompatibility complex influences the ethiopathogenesis of MS-like disease in primates at multiple levels

B A 't Hart et al. Hum Immunol. 2001 Dec.

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease primarily affecting the central nervous system. Of the many candidate polymorphic major histocompatibility complex (MHC) and non-MHC genes contributing to disease susceptibility, including those encoding effector (cytokines and chemokines) or receptor molecules within the immune system (MHC, TCR, Ig or FcR), human leukocyte antigen (HLA) class II genes have the most significant influence. In this article we put forward the hypothesis that the influence of HLA genes on the risk to develop MS is actually the sum of multiple antigen presenting cell (APC) and T-cell interactions involving HLA class I and class II molecules. This article will also discuss that, because of the genetic and immunologic similarity to humans, autoimmune models of MS in non-human primates are the experimental models "par excellence" to test this hypothesis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Compston A, Ebers G, Lassmann H, McDonald I, Matthews B, Wekerle H. McAlpine’s Multiple Sclerosis, 3rd edition. Churchill Livingstone; London: 1998.
    1. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000;47:707. - PubMed
    1. Wilkin T. Autoimmunity: attack, or defence? The case for a primary lesion theory. Autoimmunity. 1989;3:57. - PubMed
    1. The Transatlantic Multiple Sclerosis Genetics Cooperative A meta-analysis of genomic screens in multiple sclerosis. Mult Scler. 2001;7:3. - PubMed
    1. Liblau R, Grautam A.M. HLA, molecular mimicry and multiple sclerosis. Rev Immunogenetics. 2000;2:95. - PubMed

Publication types